Copyright
©The Author(s) 2016.
World J Hepatol. Jun 18, 2016; 8(17): 739-748
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.739
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.739
Figure 1 Kaplan-Meier transplant-free survival of 138 outpatients with cirrhosis stratified according to insulin-like growth factor-binding protein 3 cut-off level of 1.
67 mcg/mL. Survival probability after a median follow-up of 20 mo was 88.6% for patients with IGFBP-3 ≥ 1.67 mcg/mL and 72.1% for those with IGFBP-3 < 1.67 mcg/mL (P = 0.015). IGFBP-3: Insulin-like growth factor-binding protein 3.
- Citation: Correa CG, Colombo BDS, Ronsoni MF, Soares e Silva PE, Fayad L, Silva TE, Wildner LM, Bazzo ML, Dantas-Correa EB, Narciso-Schiavon JL, Schiavon LL. Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis. World J Hepatol 2016; 8(17): 739-748
- URL: https://www.wjgnet.com/1948-5182/full/v8/i17/739.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i17.739